Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age
Clinical trial NCT02285998 · COMPLETED
Trial details
- NCT number
- NCT02285998
- Sponsor
- Protein Sciences Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 9003
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.